CPHI.US China Pharma Holdings Inc

Healthcare Pharmaceuticals USA Stocks
0.5181 USD
Close of Nov 14, 2026
0.5000 8.10
Market cap
USD 22.3M
P/E
-
P/B
0.67x
ROE
-14.4%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is CPHI.US undervalued?

Graham number

The Graham number of China Pharma Holdings Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

China Pharma Holdings Inc fundamental analysis

No fundamental analysis for China Pharma Holdings Inc yet.

China Pharma Holdings Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About China Pharma Holdings Inc

China Pharma Holdings, Inc. develops, manufactures, and markets pharmaceutical products for human use in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes …

Full company profile